While it is possible that hyperactivation of MYC promotes the growth of Vk*MYC MM cells irrespective of microenvironmental changes, it is also possible that the anti-tumorigenic effects of CR are being counteracted by pro-tumorigenic changes. This evidence concerns the gene MYC and Miyoshi myopathy.